In vivo production of cyclic peptides

Details In vivo production of cyclic peptides In vivo production of cyclic peptides

2007-04-24

2007-04-24

Kerr, Kathleen M. (Department: 1656)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

Cyclic peptides

C530S331000

Reexamination Certificate

active

11011880

ABSTRACT:
The present invention relates ti methods and compositions utilizing inteins to generated libraries of cyclic peptides in vivo.

REFERENCES:
patent: 6153380 (2000-11-01), Nolan et al.
patent: 6531316 (2003-03-01), Patten et al.
patent: 2003/0068649 (2003-04-01), Doberstein
patent: 2004/0053324 (2004-03-01), Wong
patent: 2004/0180353 (2004-09-01), Booher
patent: 2004/0236519 (2004-11-01), Marshall et al.
patent: 2005/0227291 (2005-10-01), Kinsella
patent: WO 00/36093 (2000-06-01), None
patent: 01/57183 (2001-08-01), None
Davies, J.S., The Cyclization of Peptides and Depsipeptides. Journal of Peptide Science. 2003. vol. 9, pp. 471-501.
Che et al. Engineering Cyclic Tetrepeptides Containing Chimeric Amino Acids as Preferred Reverse-Turn Scaffolds. Journal of Medicinal Chemistry. 2006. vol. 49, pp. 111-124.
Evans et al., The In Vitro Ligation of Bacterially Expressed Proteins Using an Intein From Methanobacterium Thermoautotorophicum, J. of Biol. Chem., 1999, 274(7): 3923-3926.
Wu et al., Protein Trans-Splicing and Functional Mini-Inteins of a Cyanobacterial DNAB Intein, Biochimica et Biophysica Acta, 1998, 1387:.
Lew et al., Protein Splicing In Vitro With a Semisynthetic Two-Component Minimal Intein, J. of Biol. Chem., 1998, 273(26), 15887-015890.
Lew et al., Characteristics of Protein Splicing in Trans Mediated by a Semisynthetic Split Intein, Biopolymers, 1999, 51(5): 355-62.
Wu et al., Protein Trans-Splicing by a Split Intein Encoded in a Split DNAE Gene of Synechocystis Sp. PCC6803, Proc. Natl. Acad. Sci., 1998, 95: 9226-9231.
Southworth et al., Control of Protein Splicing by Intein Fragment Reassembly, EMBO Journal, 1998, 17(4): 918-926.
Brennand, D.M. et al. “Identification of a cyclic peptide inhibitor of platelet-derived growth factor-BB receptor-binding and mitogen-induced DNA synthesis in human fibroblasts.”FEB Lett. Aug. 11, 1997;413(1):70-4.
Camarero et al., “Chemical Synthesis of a Circular Protein Domain: Evidence for Folding-Assis,”Angew. Chem. 37(3):347-349 (1998).
Camarero and Muir, “Biosynthesis of a Head-to-Tail Cyclized Protein with Improved Biological Activity,”J Am Chem Soc; 1999; 121(23); 5597-5598.
Camarero and Muir, “Chemoselective backbone cyclization of unprotected peptides,”Chem Commun1997(15):1369-1370 (1997).
Eriksson, J.E. et al. “Rapid microfilament reorganization induced in isolated rat hepatocytes by microcystin-LR, a cyclic peptide toxin.”Exp Cell Res. Nov. 1989;185(1):86-100.
Evans, T.C. Jr, et al., “Semisynthesis of cytotoxic proteins using a modified protein splicing element.”Protein Sci. Nov. 1998;7(11):2256-64.
Evans, T.C. Jr, et al., “The cyclization and polymerization of bacterially expressed proteins using modified self-splicing inteins.”J Biol Chem. Jun. 25, 1999;274(26):18359-63.
Friedler, A., et al., “Backbone cyclic peptide, which mimics the nuclear localization signal of human immunodeficiency virus type 1 matrix protein, inhibits nuclear import and virus production in nondividing cells.” Biochemistry. Apr. 21, 1998;37(16):5616-22.
Goldenberg, D.P. and Creighton, T.E. “Circular and circularly permuted forms of bovine pancreatic trypsin inhibitor.”J Mol Biol. Apr. 5, 1983;165(2):407-13.
Hruby, V.J., et al., “Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic considerations.”Biochem J. Jun. 1, 1990;268(2):249-62.
Hruby, V.J. “Conformational restrictions of biologically active peptides via amino acid side chain groups.”Life Sci. Jul. 19, 1982;31(3):189-99.
Iwai, H. and Pluckthun, A. “Circular beta-lactamase: stability enhancement by cyclizing the backbone.”FEBS Lett. Oct. 8, 1999;459(2):166-72.
Jackson, D.Y. et al., “Enzymatic Cyclization of Linear Peptide Esters Using Subtiligase,”J Am Chem Soc117(2):819-820 (1995).
Jois, S.D. et al., “A Ca2+ binding cyclic peptide derived from the alpha-subunit of LFA-1: inhibitor of ICAM-1/LFA-1-mediated T-cell adhesion.”J Pept Res. Jan. 1999;53(1):18-29.
Kimura, K., et al. “Propeptin, a new inhibitor of prolyl endopeptidase produced by Microbispora. I. Fermentation, isolation and biological properties.”J Antibiol(Tokyo). May 1997;50(5):373-8.
Koivunen, E., et al., “Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins.”Biotechnology(N Y). Mar. 1995;13(3):265-70.
Scott, C.P. et al. “Production of cyclic peptides and proteins in vivo.”Proc Natl Acad Sci USA. Nov. 23, 1999;96(24):13638-43.
Southworth, M.W. et al., “Control of protein splicing by intein fragment reassembly.”EMBO J. Feb. 16, 1998;17(4):918-26.
Tam, J.P. and Lu, Y.A. “A biomimetic strategy in the synthesis and fragmentation of cyclic protein.”Protein Sci. Jul. 1998;7(7):1583-92.
Wood, D.W., et al. “A genetic system yields self-cleaving inteins for bioseparations.”Nat Biotechnol.Sep. 1999;17(9):889-92.
Zhang, L. and Tam, J.P., “Synthesis and Application of Unprotected Cyclic Peptides as Building Blocks,”J Am Chem Soc119(10):2363-2370 (1997).
Evans, T.C. et al., “Proteintrans-Splicing and Cyclization by a Naturally Split Intein from thednaEGene ofSynechocystisSpecies PCC6803,”J Biol Chem275(13):9091-9094 (2000).

Affiliated with

Also associated with

Rating

In vivo production of cyclic peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with In vivo production of cyclic peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and In vivo production of cyclic peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3758969